Making health happen together
As the largest Canadian-based pharmaceutical company, a top-5 supplier of generic medications in the United States, and a partner of choice in the Americas for pharmaceutical licensing and product acquisitions, Apotex plays a vital role in supporting the health journeys for millions of people.
Our 2024 Sustainability Report showcases our work as A Force for Health, advancing health with relentless determination, delivering access to medicines and health products with uncompromising quality, and unlocking new possibilities for patients, consumers, and communities through partnerships.
Read our inaugural 2024 Sustainability Report here
Report highlights
In 2024, we celebrated Apotex’s 50-year anniversary and the impact we have made. Highlights include:
Environmental
Our robust Environmental, Health, and Safety (EHS) management system ensures regulatory compliance and enhances efficient management of waste and water resources.
Continuing to reduce our Scope 1 and Scope 2 emissions, with renewable and low-carbon sources supplying more than 81 percent of our global consumption in 2024.
Advancing our decarbonization journey across our global sites
Social
We work to empower all stakeholders to advance our shared journey of health.
Improving healthcare system sustainability around the world through access to generic medicines, including in Canada, where Apotex products have provided more than $18 billion in savings over the last five years, and more than $50 billion over the last 50 years.
Product donations totaling more than $45 million, reaching communities in nearly 80 countries over our 20-year partnership with Health Partners International Canada.
Governance
Our governance structure is designed to ensure accountability for Apotex’s performance and its future impacts.
Toward the end of the year, we welcomed a new Head of Sustainability to lead our environmental, social, and governance (ESG) efforts.